应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RDC 罗文
退市 12-09 16:00:00 EST
10.93
+0.00
0.00%
最高
10.93
最低
10.93
成交量
0.00
今开
10.93
昨收
10.93
日振幅
0.00%
总市值
13.91亿
流通市值
11.58亿
总股本
1.27亿
成交额
0.00
换手率
0.00%
流通股本
1.06亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
全球首个零辐射核药研发生产基地蓄势待发,远大医药创新产品管线夯实核药国际领军地位
新浪医药 · 05-08
全球首个零辐射核药研发生产基地蓄势待发,远大医药创新产品管线夯实核药国际领军地位
股价大涨15%!远大医药(00512)全球核药龙头地位再夯实 又一RDC治疗产品迈入国际多中心III期临床
智通财经 · 05-07
股价大涨15%!远大医药(00512)全球核药龙头地位再夯实 又一RDC治疗产品迈入国际多中心III期临床
远大医药:全球创新RDC药物GPN02006研发迎来新突破
每日经济新闻 · 04-21
远大医药:全球创新RDC药物GPN02006研发迎来新突破
全球创新GPC-3靶向RDC临床突破!远大医药(00512)破解中国肝癌早诊难题,剑指肝癌精准诊疗百亿蓝海
智通财经网 · 04-21
全球创新GPC-3靶向RDC临床突破!远大医药(00512)破解中国肝癌早诊难题,剑指肝癌精准诊疗百亿蓝海
核药龙头传利好,远大医药(00512)全球创新RDC再获研发进展,或提供脑胶质瘤治疗新选择
智通财经 · 04-16
核药龙头传利好,远大医药(00512)全球创新RDC再获研发进展,或提供脑胶质瘤治疗新选择
报名开启!艳阳三月,去益阳南县跑半马赏罗文花海
华声在线 · 02-14
报名开启!艳阳三月,去益阳南县跑半马赏罗文花海
由前花旗集团高管创立的初创公司Receipts Depositary将推出XRP支持的证券
金色财经 · 02-07
由前花旗集团高管创立的初创公司Receipts Depositary将推出XRP支持的证券
罗文看望慰问春节期间一线值班人员
财经自媒体 · 01-28
罗文看望慰问春节期间一线值班人员
【券商聚焦】国元国际维持远大医药(00512)“买入”评级 料RDC创新产品推动公司业绩继续上升
金吾财讯 · 2024-12-27
【券商聚焦】国元国际维持远大医药(00512)“买入”评级 料RDC创新产品推动公司业绩继续上升
远大医药全球创新RDC药物TLX250-CDx完成国内III期临床首例患者入组给药
经济参考网 · 2024-11-28
远大医药全球创新RDC药物TLX250-CDx完成国内III期临床首例患者入组给药
下任美财长持续"难产",罗文成特朗普财长热门人选
国际金融报 · 2024-11-21
下任美财长持续"难产",罗文成特朗普财长热门人选
情况有变!这位亿万富翁成为美国财长“头号竞争者”
金十数据 · 2024-11-21
情况有变!这位亿万富翁成为美国财长“头号竞争者”
宝马将在韩国投资650亿韩元,扩增零部件物流中心
IT之家 · 2024-11-11
宝马将在韩国投资650亿韩元,扩增零部件物流中心
罗文在上海调研平台经济工作
中国质量新闻网 · 2024-11-06
罗文在上海调研平台经济工作
加载更多
公司概况
公司名称:
罗文
所属市场:
NYSE
上市日期:
--
主营业务:
罗文公司于2012年5月4日在英格兰和威尔士成立,是Rowan Companies, Inc. (RCI)的发行继承人,公司是提供国际及国内离岸钻井承包服务的主要供应商。Rowan于1947年成立于特拉华州并且继承了Rowan Drilling Company, Inc.的钻井承包业务。公司利用机群31自升式海上移动式钻井平台(自升式钻井平台)提供离岸合同钻井服务。公司的主要重点是高规格的自升式钻井平台、客户使用的探测和开发钻井、在一些地区的修井操作。
发行价格:
--
{"stockData":{"symbol":"RDC","market":"US","secType":"STK","nameCN":"罗文","latestPrice":10.93,"timestamp":1575925200000,"preClose":10.93,"halted":4,"volume":0,"delay":0,"floatShares":105959169,"shares":127294643,"eps":-2.74,"marketStatus":"退市","change":0,"latestTime":"12-09 16:00:00 EST","open":10.93,"high":10.93,"low":10.93,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.74,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752739200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":-73684800000,"exchange":"NYSE","adjPreClose":10.93,"volumeRatio":0},"requestUrl":"/m/hq/s/RDC","defaultTab":"news","newsList":[{"id":"2533183719","title":"全球首个零辐射核药研发生产基地蓄势待发,远大医药创新产品管线夯实核药国际领军地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2533183719","media":"新浪医药","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533183719?lang=zh_cn&edition=full","pubTime":"2025-05-08 08:46","pubTimestamp":1746665181,"startTime":"0","endTime":"0","summary":"远大医药目前是拥有进入中国III期临床研究中诊断和治疗类RDC创新药总计储备最多的企业,也是全球范围内在核药抗肿瘤领域拥有最丰富产品管线和诊疗一体化布局的创新药企之一,是名副其实的全球核药领军企业。值得注意的是,远大医药用于诊断前列腺癌的全球创新RDC产品TLX591-CDx计划于今年二季度完成中国III期临床的全部患者入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508085210a475fb05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508085210a475fb05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLX","RDC"],"gpt_icon":0},{"id":"2533693938","title":"股价大涨15%!远大医药(00512)全球核药龙头地位再夯实 又一RDC治疗产品迈入国际多中心III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2533693938","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533693938?lang=zh_cn&edition=full","pubTime":"2025-05-07 20:53","pubTimestamp":1746622387,"startTime":"0","endTime":"0","summary":"当日晚间,公司再度传来捷报,其用于治疗前列腺癌的全球创新放射性核素偶联药物 TLX591 加入国际多中心III期临床试验的申请已获得国家药监局正式受理。目前,远大医药在核药抗肿瘤诊疗板块已有4款RDC创新药获批开展注册性临床研究,其中3款已进入III期临床阶段。值得注意的是,远大医药用于诊断前列腺癌的全球创新RDC产品TLX591-CDx计划于今年二季度完成中国III期临床的全部患者入组。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","III","00512","RDC","BK4134"],"gpt_icon":0},{"id":"2529656805","title":"远大医药:全球创新RDC药物GPN02006研发迎来新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2529656805","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529656805?lang=zh_cn&edition=full","pubTime":"2025-04-21 20:17","pubTimestamp":1745237844,"startTime":"0","endTime":"0","summary":"每经AI快讯,远大医药公告称,集团合作开发的用于诊断肝细胞癌(HCC)的全球创新放射性核素偶联药物(RDC)GPN02006,在中国开展的研究者发起的临床研究(IIT临床研究),近日取得了里程碑式突破,并于成都2025未来XDC新药大会中公开发表了临床结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504213383222841.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504213383222841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","00512","RDC"],"gpt_icon":0},{"id":"2529874382","title":"全球创新GPC-3靶向RDC临床突破!远大医药(00512)破解中国肝癌早诊难题,剑指肝癌精准诊疗百亿蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874382","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529874382?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:52","pubTimestamp":1745232777,"startTime":"0","endTime":"0","summary":"直击肝细胞癌精准诊疗痛点,GPC-3靶向突破领跑全球原发性肝癌中是全球第六大常见癌症和第三大癌症死亡原因。因此,对HCC患者精准诊断和精准治疗,是提高患者预后、降低患者死亡风险的重要手段。此外,针对GPC-3靶点的治疗类RDC产品也已列入公司的研发计划中,有望实现对HCC患者的RDC诊疗一体化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["RDC","LU2237443382.USD","BK1191","BK4159","LU2237443549.SGD","BK4588","LU2237443978.SGD","00512","LU2237443622.USD","BK4585","GPC"],"gpt_icon":0},{"id":"2527029923","title":"核药龙头传利好,远大医药(00512)全球创新RDC再获研发进展,或提供脑胶质瘤治疗新选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2527029923","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527029923?lang=zh_cn&edition=full","pubTime":"2025-04-16 18:42","pubTimestamp":1744800148,"startTime":"0","endTime":"0","summary":"该产品已获FDA孤儿药认定。相比之下,仅接受EBRT治疗的复发性胶质母细胞瘤患者的中位生存期仅为9.9个月。未来若远大医药TLX101开发进展顺利,则有望提供全新的胶质母细胞瘤治疗手段,并为公司提供新的业绩增长点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00512","BK1191","RDC"],"gpt_icon":0},{"id":"2511663584","title":"报名开启!艳阳三月,去益阳南县跑半马赏罗文花海","url":"https://stock-news.laohu8.com/highlight/detail?id=2511663584","media":"华声在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511663584?lang=zh_cn&edition=full","pubTime":"2025-02-14 18:03","pubTimestamp":1739527380,"startTime":"0","endTime":"0","summary":"2月14日,记者获悉,目前赛事报名通道已开启,即日起至2025年3月8日,选手可通过相关平台参与报名。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-02-14/doc-inekmyre6718616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2509774779","title":"由前花旗集团高管创立的初创公司Receipts Depositary将推出XRP支持的证券","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774779","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509774779?lang=zh_cn&edition=full","pubTime":"2025-02-08 05:58","pubTimestamp":1738965529,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.coindesk.com/markets/2025/02/07/startup-founded-by-citi-alumni-to-launch-xrp-backed-securities?_gl=1*1303ezt*_up*MQ..*_ga*MTA0MzQ0MDM0Mi4xNzM4Njg4MDIw*_ga_VM3STRYVN8*MTczODk0NTI0OS4yMS4xLjE3Mzg5NTYxOTQuMC4wLjEyMzM0MTU2Mjk.","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["09439","BK4190","BK4207","09042","83042","LU0477156953.USD","DTC.AU","BK7016","ETH.USD.HKCC","ADR.AU","SEC.AU","BK4504","03439","BTC.USD.HKCC","03009","BK1611","LU1668664300.SGD","LU0648001328.SGD","BK7094","ETH","RDC","03046","LU1267930227.SGD","IBIT","03042","03008","BK4588","09179","BTCmain","BTC","LU0170899867.USD","LU0320765646.SGD","161027","LU2417539215.USD","IE00BSNM7G36.USD","BTC.USD.CC","BK4534","BK4594","09009","03179","RDC.AU","09008","DTC","LU0130517989.USD","MSTU","XBTmain","09046","BTC.AU","LU1791807156.HKD"],"gpt_icon":0},{"id":"2506567854","title":"罗文看望慰问春节期间一线值班人员","url":"https://stock-news.laohu8.com/highlight/detail?id=2506567854","media":"财经自媒体","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506567854?lang=zh_cn&edition=full","pubTime":"2025-01-28 16:00","pubTimestamp":1738051200,"startTime":"0","endTime":"0","summary":"来源:市说新语1月28日除夕上午,市场监管总局党组书记、局长罗文到总局机关检查值守应急工作,电话连线地方市场监管部门,慰问一线值班人员,对节日值班工作提出明确要求。罗文强调,春节是中华民族最重要的传统节日之一,维护好春节期间市场秩序和安全稳定意义十分重大。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/xwzmt/2025-01-28/doc-inehpimz0094320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2494826134","title":"【券商聚焦】国元国际维持远大医药(00512)“买入”评级 料RDC创新产品推动公司业绩继续上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2494826134","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494826134?lang=zh_cn&edition=full","pubTime":"2024-12-27 13:31","pubTimestamp":1735277490,"startTime":"0","endTime":"0","summary":"公司秉持“自主研发+全球扩展”战略,目前国内已有四款RDC创新产品获批开展临床试验,3款处于临床研究III期。RDC市场空间广阔,将推动公司业绩继续上升,并有望提升估值,该行给予公司目标价格为8.28港元,对应2024年13.8倍PE,较现价有74.6%的上涨空间。维持‘买入’评级。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1950330","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDC","00512"],"gpt_icon":0},{"id":"2486391441","title":"远大医药全球创新RDC药物TLX250-CDx完成国内III期临床首例患者入组给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2486391441","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486391441?lang=zh_cn&edition=full","pubTime":"2024-11-28 18:21","pubTimestamp":1732789267,"startTime":"0","endTime":"0","summary":"11月28日,远大医药公告称,其用于诊断肾透明细胞癌(ccRCC)的全球创新放射性核素偶联药物(RDC)TLX250-CDx已完成国内III期临床研究的首例患者入组给药。据介绍,TLX250-CDx(89Zr-TLX250)是一款全球创新的适用于ccRCC诊断的放射性核素偶联药物,其靶点为碳酸酐酶IX(CAIX),CAIX在ccRCC和其他许多癌种中过度表达。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411283253859877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4134","00512","RDC","III","BK1191"],"gpt_icon":0},{"id":"2485446289","title":"下任美财长持续\"难产\",罗文成特朗普财长热门人选","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446289","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446289?lang=zh_cn&edition=full","pubTime":"2024-11-21 18:37","pubTimestamp":1732185420,"startTime":"0","endTime":"0","summary":"据报道,私募股权大亨马克·罗文 已成为特朗普新一届政府财政部长职位的热门人选。罗文现任阿波罗全球管理公司负责人,在特朗普第一届政府期间曾为疫情时期的金融市场紧急对策提供建议,而其所在的阿波罗公司目前管理资产超过7000亿美元。其中,预测机构将沃什列为最可能当选的人选,而贝森特排名第二,罗文和哈格蒂则紧随其后。即便贝森特未能当选财政部长,他仍有望出任国家经济委员会主席。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-21/doc-incwvpzk1347920.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-21/doc-incwvpzk1347920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0},{"id":"2484111720","title":"情况有变!这位亿万富翁成为美国财长“头号竞争者”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484111720","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484111720?lang=zh_cn&edition=full","pubTime":"2024-11-21 09:58","pubTimestamp":1732154293,"startTime":"0","endTime":"0","summary":"预测网站显示前美联储理事沃什可能会在这场“财长之争”中获胜,一些知情人士则透露称,这位资管巨头CEO才是“头号竞争者”……","market":"hk","thumbnail":"https://static.tigerbbs.com/c4e15bc5ec6e1753390253b04c7adb1f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c4e15bc5ec6e1753390253b04c7adb1f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://xnews.jin10.com/webapp/details.html?id=153884&type=news&data_type=0","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"xnew_highlight","symbols":["IE00B3S45H60.SGD","IE00B19Z3B42.SGD","LU0006061336.USD","LU0106831901.USD","LU1323610961.USD","RDC.AU","BK4184","IE00B19Z3581.USD","LU1668664300.SGD","IE0002270589.USD","IE00B775SV38.USD","RDC","LU1791807156.HKD","BK4135","APO","BIDU"],"gpt_icon":1},{"id":"2482885202","title":"宝马将在韩国投资650亿韩元,扩增零部件物流中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2482885202","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482885202?lang=zh_cn&edition=full","pubTime":"2024-11-11 19:09","pubTimestamp":1731323362,"startTime":"0","endTime":"0","summary":"IT之家 11 月 11 日消息,据韩联社报道,宝马集团韩国分公司今日表示,到 2027 年,将对安城区域物流中心 进行 650 亿韩元投资,使园区总面积扩大到目前的 1.5 倍。宝马韩国公司今日在位于京畿道安城市的物流中心举行记者会,公布上述计划。宝马韩国公司已于 2017 年投资 1300 亿韩元兴建安城区域物流中心。若算上当天发布的投资计划,该公司对该物流中心的累计投资额将达 1950 亿韩元。去年宝马在韩国销量赶超梅赛德斯-奔驰,登顶年度进口车销量榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8ePrCcBC10s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["RDC"],"gpt_icon":0},{"id":"2481241746","title":"罗文在上海调研平台经济工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2481241746","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481241746?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:11","pubTimestamp":1730884260,"startTime":"0","endTime":"0","summary":"转自:市说新语11月5日,市场监管总局党组书记、局长罗文在上海市调研平台经济工作。罗文一行实地调研得物集团,详细了解企业发展情况。随后,罗文主持召开座谈会,就促进平台企业健康发展与企业代表进行了深入交流,听取不同类型的平台企业在经营活动中存在的困难、诉求和政策需求,来自上海的8家网络交易平台参加座谈。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-06/doc-incvckzx3342010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RDC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rowan.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"罗文公司于2012年5月4日在英格兰和威尔士成立,是Rowan Companies, Inc. (RCI)的发行继承人,公司是提供国际及国内离岸钻井承包服务的主要供应商。Rowan于1947年成立于特拉华州并且继承了Rowan Drilling Company, Inc.的钻井承包业务。公司利用机群31自升式海上移动式钻井平台(自升式钻井平台)提供离岸合同钻井服务。公司的主要重点是高规格的自升式钻井平台、客户使用的探测和开发钻井、在一些地区的修井操作。","exchange":"NYSE","name":"罗文","nameEN":"Rowan Companies PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗文(RDC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗文(RDC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗文,RDC,罗文股票,罗文股票老虎,罗文股票老虎国际,罗文行情,罗文股票行情,罗文股价,罗文股市,罗文股票价格,罗文股票交易,罗文股票购买,罗文股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗文(RDC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗文(RDC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}